IMAC HOLDINGS INC (BACK)

Company Profile

IMAC Holdings, Inc. provides medical services through integrated medicine and chiropractic regeneration centers. The company is headquartered in Franklin, Tennessee and currently employs 2 full-time employees. The company went IPO on 2019-02-13. The firm is focused on innovative medical advancements and care in the oncology, neurological, and orthopedic medical specialties. The firm is focused on providing natural, non-opioid solutions to pain as consumers demand conservative treatments for an aging population. Its Investigational New Drug division conducted a clinical trial for its investigational compound utilizing umbilical cord-derived allogenic mesenchymal stem cells for the treatment of bradykinesia due to Parkinson’s disease. The firm is also engaged in providing the precision medicine business. The firm's technology, through its patented phosphoprotein and protein biomarker platform and lab developed tests (LDTs), targets multiple areas of oncology and drug development. Its LDTs are utilized by oncologists across the United States to assist in making the targeted treatment plan for their patients with advanced breast cancer.

Company Info

IMAC HOLDINGS INC

3401 Mallory Lane, Suite 100

Franklin TENNESSEE

P: 18442664622

Employees: 3

Website: https://imacregeneration.com/